NCT02159352View on ClinicalTrials.gov

Study Assessing the Effects of Darunavir/Ritonavir or Lopinavir/Ritonavir on the Pharmacokinetics of Daclatasvir in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Hepatitis C
Interventions
DRUG

Daclatasvir

DRUG

Darunavir

DRUG

Ritonavir

DRUG

Lopinavir/Ritonavir

Trial Locations (1)

78209

Healthcare Discoveries, Llc D/B/A Icon Development Solutions, San Antonio

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY